Amgen’s anti-obesity drug reduces weight by up to 20%
Amgen’s experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average, according to a year-long mid-stage trial. The data fell short of investors’ lofty expectations and sent shares down 8% before the market opened on Tuesday.
POPULAR POSTS
North Carolina city sues Duke Energy over climate crisis
December 6, 2024
Earthquake of magnitude 5.7 strikes western Iran
December 6, 2024
Soy traders push to soften ban on buying Amazon produce
December 6, 2024
Tom Tykwer’s ‘The Light’ will open the 2025 Berlin Film Festival
December 6, 2024
LIVE STREAM